Wedbush Raises CVH PT To $35

Wedbush has issued a report raising the Price Target on Coventry Health Care CVH from $32 to 435 a share. According to the report, “Our Increased Estimates Reflect our Belief that Utilization and Flu Trends Remain Moderate. We also see potential upside from a modest improvement in leveraging overhead expenses as well as membership gains in several markets from March enrollment data.” CVH has a Neutral Rating and closed at $31.67 a share yesterday.